Yoon, Seonghae
Sangmi Lee, Seonghae Yoon, In-Jin Jang
Evaluation of drug prescribing patterns and therapeutic drug monitoring practice using electronic medical records.
Sci Rep
2022;12(1):21377-21377
Hyounggyoon Yoo, Seonghae Yoon, In-Jin Jang, Kyung-Sang Yu, Joon Young Hyon, Jungi Hwang, Inyoung Hwang, Jung Sunwoo, Jae-Yong Chung
Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects.
Pharmaceuticals (Basel)
2022;15(11):0-0
Seonghae Yoon, Seongmee Jeong, Eben Jung, Ki Soon Kim, Inseung Jeon, Yujin Lee, Joo-Youn Cho, Woo-Yong Oh, Jae-Yong Chung
Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem.
Sci Rep
2021;11(1):19150-19150
Eun Sun Kim, Byoung Soo Kwon, Jong Sun Park, Jae-Yong Chung, Soo Hyun Seo, Kyoung Un Park, Junghan Song, Seonghae Yoon, Jae Ho Lee
Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis.
Br J Clin Pharmacol
2021;87(9):3492-3500
Koung Jin Suh, Seonghae Yoon, Jin Won Kim, Seo Hyun Yoon, Ji-Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapy.
J Geriatr Oncol
2021;12(6):922-929
Ki Young Huh, Eunwoo Kim, Soyoung Lee, Hyounggyoon Yoo, Seonghae Yoon, Kyung-Sang Yu, Jae-Yong Chung
Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019.
Front Pharmacol
2021;12:651790-651790
Yoonhyuk Jang, Seonghae Yoon, Tae-Joon Kim, SeungHwan Lee, Kyung-Sang Yu, In-Jin Jang, Kon Chu, Sang Kun Lee
Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy.
Sci Rep
2021;11(1):6370-6370
June Young Chun, Kyoung-Ho Song, Dong-Eun Lee, Joo-Hee Hwang, Hyun Gul Jung, Eunjeong Heo, Hyung-Sook Kim, Seonghae Yoon, Jeong Su Park, Pyoeng Gyun Choe, Jae-Yong Chung, Wan Beom Park, Ji Hwan Bang, Hee Hwang, Kyoung-Un Park, Sang Won Park, Nam Joong Kim, Myoung-Don Oh, Eu Suk Kim, Hong Bin Kim
Impact of a computerised clinical decision support system on vancomycin loading and the risk of nephrotoxicity.
Int J Med Inform
2021;149:104403-104403
YoonSeonghae, LeeHeechan, JiSang-Chun, YoonSeo Hyun, ChoJoo-Youn, ChungJae-Yong
Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function.
Clin Pharmacol Drug Dev
2021;10(1):68-77
Seonghae Yoon, Heechan Lee, Sang-Chun Ji, Seo Hyun Yoon, Joo-Youn Cho, Jae-Yong Chung
Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function.
Clin Pharmacol Drug Dev
2020;10(1):68-77
Yujin Lee, Woori Chae, Seonghae Yoon, Jae-Yong Chung, Joo-Youn Cho
Development and validation of a method for the simultaneous quantification of endogenous steroids metabolized by CYP3A.
Transl Clin Pharmacol
2020;28(2):73-82
Hark Kyun Kim, Jeong Won Kang, Young-Whan Park, Jung Young Kim, Minchae Kim, Soo Jin Kim, Se-Mi Kim, Keun Ho Ryu, Seonghae Yoon, Yun Kim, Joo-Youn Cho, Keun Seok Lee, Tak Yun, Kiwon Kim, Mi Hyang Kwak, Tae-Sung Kim, Jinsoo Chung, Joong-Won Park
Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumors.
Pharmacol Res Perspect
2020;8(2):e00568-e00568
박중완, 윤성혜
Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumors.
Pharmacol Res Perspect
2020;8(2):e00568-e00568
박중완, 윤성혜
Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumors.
Pharmacol Res Perspect
2020;8(2):e00568-e00568
Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects
SCI REP-UK
2019;9(1)
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
LUNG CANCER
2019;135:66-72
A safety, pharmacokinetic, pharmacogenomic and population pharmacokinetic analysis of the third-generation EGFR TKI, olmutinib (HM61713), after single oral administration in healthy volunteers
BASIC CLIN PHARMACOL
2019;125(4):370-381
URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers
RHEUMATOLOGY
2019;58(11):1976-1984
Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population
J CLIN PHARMACOL
2019;59(8):1085-1092
A pharmacokinetic drug-drug interaction study between pregabalin and tramadol in healthy volunteers
EUR J CLIN PHARMACOL
2018;74(12):1605-1613
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
SCI REP-UK
2018;8(1)
Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic
DRUG DES DEV THER
2018;12:1707-1714
Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with Japanese
DRUG DES DEV THER
2018;12:1045-1051
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea
CANCER MED-US
2018;7(5):1814-1823
Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram
BASIC CLIN PHARMACOL
2018;122(2):233-238
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
INT J CLIN PHARM TH
2017;61(6):928-934
A bioequivalence study of two omeprazole formulations in healthy male volunteers
INT J CLIN PHARM TH
2016;54(11):928-934
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
INT J ANTIMICROB AG
2016;48(1):106-110
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects
DRUG DES DEV THER
2015;9:5033-5049